Profilo
Il Dr. Loren Aguiar, MD, è un vicepresidente di ricerca e sviluppo alla Biohaven Pharmaceutical Holding Co. Ltd.
Precedenti posizioni note di Loren Aguiar
| Società | Posizione | Fine |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOHAVEN LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Loren Aguiar
